Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021

Although COVID-19 generally results in milder disease in children and adolescents than in adults, severe illness from COVID-19 can occur in children and adolescents and might require hospitalization and intensive care unit (ICU) support (1-3). It is not known whether the B.1.617.2 (Delta) variant,* which has been the predominant variant of SARS-CoV-2 (the virus that causes COVID-19) in the United States since late June 2021,† causes different clinical outcomes in children and adolescents compared with variants that circulated earlier. To assess trends among children and adolescents, CDC analyzed new COVID-19 cases, emergency department (ED) visits with a COVID-19 diagnosis code, and hospital admissions of patients with confirmed COVID-19 among persons aged 0-17 years during August 1, 2020-August 27, 2021. Since July 2021, after Delta had become the predominant circulating variant, the rate of new COVID-19 cases and COVID-19-related ED visits increased for persons aged 0-4, 5-11, and 12-17 years, and hospital admissions of patients with confirmed COVID-19 increased for persons aged 0-17 years. Among persons aged 0-17 years during the most recent 2-week period (August 14-27, 2021), COVID-19-related ED visits and hospital admissions in the states with the lowest vaccination coverage were 3.4 and 3.7 times that in the states with the highest vaccination coverage, respectively. At selected hospitals, the proportion of COVID-19 patients aged 0-17 years who were admitted to an ICU ranged from 10% to 25% during August 2020-June 2021 and was 20% and 18% during July and August 2021, respectively. Broad, community-wide vaccination of all eligible persons is a critical component of mitigation strategies to protect pediatric populations from SARS-CoV-2 infection and severe COVID-19 illness.

On September 3, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr).
Although COVID-19 generally results in milder disease in children and adolescents than in adults, severe illness from COVID-19 can occur in children and adolescents and might require hospitalization and intensive care unit (ICU) support (1)(2)(3). It is not known whether the B.1.617.2 (Delta) variant,* which has been the predominant variant of SARS-CoV-2 (the virus that causes COVID-19) in the United States since late June 2021, † causes different clinical outcomes in children and adolescents compared with variants that circulated earlier. To assess trends among children and adolescents, CDC analyzed new COVID-19 cases, emergency department (ED) visits with a COVID-19 diagnosis code, and hospital admissions of patients with confirmed COVID-19 among persons aged 0-17 years during August 1, 2020-August 27, 2021. Since July 2021, after Delta had become the predominant circulating variant, the rate of new COVID-19 cases and COVID-19related ED visits increased for persons aged 0-4, 5-11, and 12-17 years, and hospital admissions of patients with confirmed COVID-19 increased for persons aged 0-17 years. Among persons aged 0-17 years during the most recent 2-week period (August 14-27, 2021), COVID-19-related ED visits and hospital admissions in the states with the lowest vaccination coverage were 3.4 and 3.7 times that in the states with the highest vaccination coverage, respectively. At selected hospitals, the proportion of COVID-19 patients aged 0-17 years who were admitted to an ICU ranged from 10% to 25% during August 2020-June 2021 and was 20% and 18% during July and August 2021, respectively. Broad, community-wide vaccination of all eligible persons is a critical component of mitigation strategies to protect pediatric populations from SARS-CoV-2 infection and severe COVID-19 illness.
CDC analyzed COVID-19 cases, ED visits with a COVID-19 diagnosis code, and hospital admissions of patients visits, and hospital admissions were averaged over a 7-day period to obtain a 7-day average. The state-specific percentage of the population aged ≥12 years who had completed the COVID-19 vaccination series as of July 31, 2021, was used to group states into vaccination coverage quartiles. † † Results were also examined by HHS Region. U.S. Census Bureau midyear 2019 population estimates § § were used to calculate vaccination coverage and cases and hospital admissions per 100,000 persons. COVID-19-associated ED visits were assessed as a percentage of all ED visits. To assess differences in COVID-19 outcomes by vaccination coverage quartile, ratios for ED visits and rate ratios for hospital admissions during the 2-week period August 14-27, 2021, along with corresponding 95% confidence intervals (CIs), were calculated. R (Version 4.1.0; R Foundation) was used for calculations. The BD Insights Research Database was used to describe indicators of severe disease among pediatric patients hospitalized with laboratory-confirmed COVID-19. ¶ ¶ CDC analyzed the monthly percentage of hospitalizations resulting in ICU admission and in invasive mechanical ventilation, and median length of hospital stay during August 1, 2020-August 21, 2021. These analyses were conducted using SAS (version 9.4; SAS Institute).*** This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy. † † † COVID-19 incidence among persons aged 0-4, 5-11, and 12-17 years during August 2020-August 2021 peaked in January 2021 at 21.2, 30.1, and 51.7 cases per 100,000 persons, respectively ( Figure 1). Incidence declined in June 2021 to a low of 1.7, 1.9, and 2.9, respectively, across the three † † Obtained from COVID-19 Data Tracker (https://covid.cdc.gov/covid-datatracker/#vaccinations_vacc-total-admin-rate-total). Persons aged 12-17 years became eligible for vaccination on May 10, 2021. Age 12 years is the current lowest age of eligibility for COVID-19 vaccination. https://www.fda.gov/ news-events/press-announcements/coronavirus-covid-19-update-fdaauthorizes-pfizer-biontech-covid-19-vaccine-emergency-use § § Population estimates as of July In the BD Insights Research Database, 1,790 COVID-19 hospitalizations occurred among persons aged 0-17 years during August 1, 2020-August 21, 2021. Median length of stay ranged from 2 to 3 days during the entire period. The percentage of hospitalizations resulting in an ICU admission ranged from 10% to 25% during August 2020-June 2021; percentages were 20% and 18% in July and August 2021, respectively ( Figure 2). The percentage of hospitalizations resulting in invasive mechanical ventilation ranged from 0% to 3% and was highest in October 2020; percentages in July and August 2021 were 2% and <1%, respectively. A total of eight in-hospital COVID-19-related deaths in persons aged 0-17 years occurred during August 2020-August 2021 (0.4% of hospitalized patients). Among 63 patients aged 0-17 years admitted to an ICU in July and August 2021, 17 (27%) were aged 0-4 years, 17 (27%) were 5-11 years, and 29 (46%) were 12-17 years. visits and hospital admissions for children and adolescents with confirmed COVID-19 were highest in states with lowest vaccination coverage, particularly states in the South, whereas in the states with the highest coverage, COVID-19 ED visits and the rate of hospital admissions among children and adolescents were lowest. These findings underscore the importance of community vaccination, in coordination with testing strategies and other prevention measures, to protect children from SARS-CoV-2 infection and severe COVID-19. Children and adolescents can experience severe acute COVID-19, which might require mechanical ventilation, or result in other complications, such as multisystem inflammatory syndrome in children (MIS-C) (2) ¶ ¶ ¶ and persistent symptoms from COVID-19 (4). Pediatric patients who have underlying medical conditions might be at risk for more severe   (5). Increases in COVID-19 ED visits and hospital admissions were observed in all four state COVID-19 vaccination coverage quartiles during June-August 2021. Although some data suggest that persons infected with the Delta SARS-CoV-2 variant might be at higher risk for hospitalization (6), it is not clear whether the Delta variant causes more severe illness in adult or pediatric populations. Although it is possible that increases in COVID-19-related ED visits and hospital admissions for pediatric patients with confirmed COVID-19 could be related to increased severity of disease for the Delta variant compared with severity for earlier circulating variants, increases in ED visits and hospitalizations could be related to other factors such as increased transmission (6).**** Pediatric ED visits and hospital admissions were higher in August 2021 in states with the lowest vaccination coverage among persons aged ≥12 years. Although the SARS-CoV-2 Delta variant is highly transmissible, only a modest decrease in vaccine effectiveness against infection with the Delta variant has been reported (7); therefore, transmission might be a major factor driving increases in ED visits and hospital admissions. However, beyond community vaccination coverage, other factors driving regional variation might include differences in implementation of other prevention measures, including masking, physical distancing, and kindergarten through grade 12 (K-12) school opening policies (8).

Discussion
This analysis found that the percentage of COVID-19 hospitalizations resulting in ICU admission has remained near 20% since Delta became the predominant SARS-CoV-2 variant. A study of children and adolescents hospitalized for COVID-19 during March 2020-July 2021 found that the proportion of those patients admitted to an ICU during the pre-Delta period (March 1, 2020-June 19, 2021) and the Delta-predominant period (June 20-July 31, 2021) did not differ (26.5% and 23.2%, respectively) (9). This same study **** Accessed September 1, 2021. https://www.cdc.gov/coronavirus/2019-ncov/ variants/delta-variant.html found a median length of stay of 3 days during the pre-Delta period and 2 days during the Delta-predominant period among hospitalized patients aged 0-17 years with COVID-19 (9). The findings in this report are subject to at least seven limitations. First, data sets used to quantify COVID-19 cases, ED visits, and hospital admissions are subject to reporting inconsistencies. Second, testing rates for SARS-CoV-2 infection in persons aged 0-17 years are lower than they are in older age groups † † † † ; therefore, pediatric case rates are likely underreported. Third, ED visits and hospital admissions were not characterized by reason for visit or admission and might include cases of MIS-C or asymptomatic SARS-CoV-2 infection. Fourth, admissions in the Unified Hospital Data Surveillance System could not be stratified by age and were only counted if the patient was "admitted to a pediatric bed." § § § § Fifth, because the BD Insights Research Database represents three children's hospitals and the remainder of patients were mostly from community hospitals, patients with severe COVID-19 might be under-or overrepresented, which might account for some differences compared with past studies. Sixth, patients are added to this database on hospital discharge; therefore, recent data do not include patients currently admitted. Finally, geographic representativeness varies across data sources. † † † † COVID-19 electronic laboratory reporting data set, accessed August 29, 2021. § § § § https://www.hhs.gov/sites/default/files/covid-19-faqs-hospitals-hospitallaboratory-acute-care-facility-data-reporting.pdf Continued assessment of trends in ED visits and admissions, including evaluation of reason for seeking medical care, could help guide public health practice, including planning for any decreases in pediatric care capacity. Evaluating more specific measures of severity (e.g., hypoxia and duration of mechanical ventilation), potential co-infection (e.g., respiratory syncytial virus), vaccination status, and underlying medical conditions might help determine whether children and adolescents infected with the Delta variant have more severe disease than do those infected with other variants. As schools resume inperson activities, CDC recommends multiple prevention measures in early child care and education programs and K-12 schools, ¶ ¶ ¶ ¶ such as masking for students and staff members and maintaining adequate ventilation to reduce transmission of SARS-CoV-2. Vaccination of eligible persons against COVID-19, especially those in close contact with children aged <12 years who are not yet eligible for vaccination, is anticipated to protect students, teachers, staff members, visitors, and other household members. Community vaccination, in coordination with testing strategies and other prevention measures, are critical to protecting pediatric populations from SARS-CoV-2 infection and severe COVID-19.

Summary
What is already know about this topic?
Severe illness from COVID-19 can and does occur in children and adolescents.
What is added by this report?
COVID-19 cases, emergency department visits, and hospital admissions increased from June to August 2021 among persons aged 0-17 years. Emergency department visits and hospital admissions in a 2-week period in August 2021 were higher in states with lower population vaccination coverage and lower in states with higher vaccination coverage.
What are the implications for public health?
Community vaccination, in coordination with testing strategies and other prevention measures, is critical to protecting pediatric populations from SARS-CoV-2 infection and severe COVID-19.